BRPI0414849A - produto medicinal e método de revestimento biocompatìvel de produtos medicinais - Google Patents

produto medicinal e método de revestimento biocompatìvel de produtos medicinais

Info

Publication number
BRPI0414849A
BRPI0414849A BRPI0414849-5A BRPI0414849A BRPI0414849A BR PI0414849 A BRPI0414849 A BR PI0414849A BR PI0414849 A BRPI0414849 A BR PI0414849A BR PI0414849 A BRPI0414849 A BR PI0414849A
Authority
BR
Brazil
Prior art keywords
medicinal
biocompatibly
coating method
products
medical products
Prior art date
Application number
BRPI0414849-5A
Other languages
English (en)
Inventor
Roland Horres
Michael Hoffmann
Volker Faust
Erika Hoffmann
Donato Di Biase
Original Assignee
Hemoteq Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102004020856A external-priority patent/DE102004020856A1/de
Application filed by Hemoteq Gmbh filed Critical Hemoteq Gmbh
Publication of BRPI0414849A publication Critical patent/BRPI0414849A/pt
Publication of BRPI0414849B1 publication Critical patent/BRPI0414849B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D181/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing sulfur, with or without nitrogen, oxygen, or carbon only; Coating compositions based on polysulfones; Coating compositions based on derivatives of such polymers
    • C09D181/06—Polysulfones; Polyethersulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/07—Stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/068—Use of macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)

Abstract

"PRODUTO MEDICINAL E MéTODO DE REVESTIMENTO BIOCOMPATìVEL DE PRODUTOS MEDICINAIS". A invenção se refere a produtos medicinais com pelo menos um revestimento de polissulfona biocompatível, bioestável por intermédio do qual a cinética de eluição do pelo menos um agente ativo incorporado e/ou depositado, antiproliferativo, antiinflamatório, antiflogístico e/ou antitrombótico pode ser controlada por intermédio da mistura de pelo menos um polímero hidrofílico em uma quantidade adequada e também uma separação local de diferentes agentes ativos e combinações de agentes ativos, respectivamente, pode ser obtida por intermédio do sistema de camada de polímeros bioestáveis, métodos de fabricação desses produtos medicinais assim como seu uso especificamente na forma de stents para a prevenção de restenose.
BRPI0414849A 2003-09-29 2004-09-29 produto medicinal e método de revestimento biocompatível de produtos medicinais BRPI0414849B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10345132 2003-09-29
US51629503P 2003-11-03 2003-11-03
DE102004020856A DE102004020856A1 (de) 2003-09-29 2004-04-28 Biokompatible, biostabile Beschichtung von medizinischen Oberflächen
US57158204P 2004-05-17 2004-05-17
PCT/DE2004/002184 WO2005032611A2 (de) 2003-09-29 2004-09-29 Biokompatible, biostabile beschichtung von medizinischen oberflächen

Publications (2)

Publication Number Publication Date
BRPI0414849A true BRPI0414849A (pt) 2006-11-21
BRPI0414849B1 BRPI0414849B1 (pt) 2017-05-16

Family

ID=34426957

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414849A BRPI0414849B1 (pt) 2003-09-29 2004-09-29 produto medicinal e método de revestimento biocompatível de produtos medicinais

Country Status (13)

Country Link
EP (1) EP1667743B1 (pt)
KR (1) KR100983440B1 (pt)
CN (1) CN101094698A (pt)
AT (1) ATE382377T1 (pt)
AU (1) AU2004277302B2 (pt)
BR (1) BRPI0414849B1 (pt)
CA (1) CA2540382C (pt)
DE (2) DE502004005857D1 (pt)
EA (1) EA011822B1 (pt)
ES (1) ES2304626T3 (pt)
NZ (1) NZ546068A (pt)
PL (1) PL1667743T3 (pt)
WO (1) WO2005032611A2 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080008364A (ko) * 2005-05-05 2008-01-23 헤모텍 아게 관 스텐트의 전면 코팅
US9278161B2 (en) * 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US20070160641A1 (en) * 2006-01-12 2007-07-12 Eun-Hyun Jang Coated medical devices and methods of making the same
CA2656635C (en) * 2006-07-03 2013-05-28 Hemoteq Ag Stent with polymeric coating comprising rapamycin as an active agent
JP5602432B2 (ja) * 2007-01-11 2014-10-08 ロバート ラマール ジュニア ビョーク 経皮的冠動脈インターベンション用の多剤溶出冠動脈ステント
RU2447901C2 (ru) 2007-01-21 2012-04-20 Хемотек Аг Медицинский продукт для лечения обтураций просветов организма и для предупреждения угрожающих повторных обтураций
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
ES2773766T3 (es) 2008-12-19 2020-07-14 Baxalta GmbH Inhibidores de TFPI y métodos de uso
EP3064230B1 (en) 2009-07-10 2019-04-10 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
WO2011008393A2 (en) 2009-07-17 2011-01-20 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
AU2011227714B2 (en) 2010-03-19 2014-09-04 Takeda Pharmaceutical Company Limited TFPI inhibitors and methods of use
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US8669360B2 (en) 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
JP5439551B2 (ja) 2011-08-15 2014-03-12 一般財団法人川村理化学研究所 ブロック共重合体の塗膜
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
CN102552405B (zh) * 2012-03-21 2013-10-16 张伟 一种肛周术后麻醉镇痛的药物组合物的制备方法
CN102579579B (zh) * 2012-03-21 2013-10-16 张伟 一种肛周术后麻醉镇痛的药物组合物
CA2867363C (en) 2012-03-21 2023-02-28 Baxter International Inc. Tfpi inhibitors and methods of use
CA2947494C (en) * 2014-05-02 2020-10-20 Research Institute At Nationwide Children's Hospital Compositions and methods for anti-lyst immunomodulation
CA3007631A1 (en) 2015-12-11 2017-06-15 Research Institute At Nationwide Children's Hospital Optimized patient specific non-linear tissue engineered vascular grafts
CN107736958A (zh) * 2017-11-29 2018-02-27 成都创客之家科技有限公司 一种钛合金药物释放血管支架
CN107669380A (zh) * 2017-11-29 2018-02-09 成都创客之家科技有限公司 一种药物洗脱血管支架
CN107736959A (zh) * 2017-11-29 2018-02-27 成都创客之家科技有限公司 一种可显影载药血管支架
CN107669381A (zh) * 2017-11-29 2018-02-09 成都创客之家科技有限公司 一种药物释放血管支架
CN107736960A (zh) * 2017-11-29 2018-02-27 成都创客之家科技有限公司 一种可显影载药钛合金支架
CN108796491B (zh) * 2018-07-05 2019-07-09 四川大学 一种具有高耐腐蚀性和表面功能化的镁基金属转化涂层及其制备方法
CN108816689B (zh) * 2018-07-05 2020-07-07 四川大学 一种具有长效抗菌性能的超亲水涂层及其制备方法
RU2686747C1 (ru) * 2018-11-08 2019-04-30 Федеральное государственное бюджетное учреждение науки Институт металлургии и материаловедения им. А.А. Байкова Российской академии наук (ИМЕТ РАН) Способ получения биодеградируемого полимерного покрытия на основе полилактида на проволоке TiNbTaZr
CN109575727A (zh) * 2018-11-28 2019-04-05 浙江大学自贡创新中心 一种防滑涂料
CN109821076B (zh) * 2019-03-13 2021-05-07 陕西师范大学 一种抗凝抗感染的多功能涂层的制备方法及抗凝抗感染的多功能材料
CN113117154B (zh) * 2019-12-31 2022-10-21 东莞市先健医疗有限公司 亲水涂层溶液、其制备方法及涂覆该涂层溶液的医疗器械

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179757A (en) * 1972-02-22 1979-12-25 Owens-Illinois, Inc. Biocompatible articles having high permeability to gases derived from polysulfones
ATE271397T1 (de) * 1997-06-24 2004-08-15 Schering Ag Mit fluoralkylgruppen beschichtete stents, verfahren zu ihrer herstellung und ihre verwendung zur restenoseprophylaxe
JP4101460B2 (ja) * 1997-10-09 2008-06-18 帝人株式会社 フッ素原子を有するポリスルホンを含む抗血栓性に優れた医療用材料
JP4121708B2 (ja) * 1998-10-13 2008-07-23 ガンブロ ルンデイア アクチーボラグ 生体適合性ポリマーフィルム

Also Published As

Publication number Publication date
EA200600470A1 (ru) 2007-02-27
NZ546068A (en) 2009-07-31
CA2540382A1 (en) 2005-04-14
DE502004005857D1 (de) 2008-02-14
PL1667743T3 (pl) 2008-06-30
WO2005032611A3 (de) 2007-03-22
EP1667743A2 (de) 2006-06-14
ATE382377T1 (de) 2008-01-15
EA011822B1 (ru) 2009-06-30
CA2540382C (en) 2012-03-06
DE112004002385D2 (de) 2006-08-31
KR20060118438A (ko) 2006-11-23
WO2005032611A2 (de) 2005-04-14
AU2004277302B2 (en) 2010-08-26
KR100983440B1 (ko) 2010-09-20
EP1667743B1 (de) 2008-01-02
ES2304626T3 (es) 2008-10-16
CN101094698A (zh) 2007-12-26
BRPI0414849B1 (pt) 2017-05-16
AU2004277302A1 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
BRPI0414849A (pt) produto medicinal e método de revestimento biocompatìvel de produtos medicinais
WO2003024455A8 (en) Stent coated with a sustained-release drug delivery and method for use thereof
WO2006047378A3 (en) Biocompatible and hemocompatible amphiphilic coatings for drug deliver
AU2002336764B2 (en) Optimized dosing for drug coated stents
DE602005016044D1 (de) Deckbeschichtung enhaltend Heparin für kontrollierte Wirkstoffabgabe
DK1448281T3 (da) Terapeutisk coat til en intravaskulært implantat
DE60235775D1 (de) Intraluminale Vorrichtung mit einer therapeutisches-mittel enthaltenden Beschichtung
WO2004030678A8 (en) Polymer compositions containing bioactive agents and methods for their use
EP1795215A3 (en) Absorbable stent comprising coating for controlling degradation and maintaining pH neutrality
WO2006014969A3 (en) Medical device having a coating layer with structural elements therein and method of making the same
ATE529068T1 (de) Mehrschichtig beschichteter stent zur kontrollierten freisetzung von wirkstoffen und verfahren zu seiner herstellung
AU2003245282A1 (en) Stent coatings with sustained drug release rate
ATE515995T1 (de) Vorrichtung zur freigabe von bioaktiven substanzen und verfahren zu deren herstellung
ATE290895T1 (de) Stents mit arzneimittelhaltigem amphiphilem polymerüberzug
ATE425777T1 (de) Stents mit wirkstofffreisetzungsbeschichtungen
DE60308256D1 (de) Beschichtetes medizinsches Implantat zur Behandlung von Gefässerkrankungen
WO2003028780A3 (en) Medical device containing light-protected therapeutic agent
WO2005034852A3 (en) Protein biomaterials and biocoacervates and methods of making and using thereof
DE602005016479D1 (de) Lokale, vaskuläre Verabreichung von Cladribin in Kombination mit Rapamycin zur Vorbeugung von Restenose nach Gefässverletzungen
EP1779816A3 (en) Stent with thin drug-eluting film
DE602005022515D1 (de) Lokale, vaskuläre Verabreichung von Etoposide in Kombination mit Rapamycin zur Vorbeugung von Restenose nach Gefässverletzungen
WO1999016416A3 (de) Beschichtete medizinische implantate, verfahren zu ihrer herstellung und ihre verwendung zur restenoseprophylaxe
WO2009097165A3 (en) Ordered coatings for drug eluting stents and medical devices
US7223282B1 (en) Remote activation of an implantable device
ATE438361T1 (de) Stent beschichtet mit dna

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: HEMOTEQ AG (DE)

Free format text: NOME ALTERADO DE: HEMOTEQ GMBH.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25E Requested change of name of applicant rejected

Owner name: HEMOTEQ AG (DE)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B25B Requested transfer of rights rejected
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2533 DE 23-07-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.